Drawing for WEHEALTH BY SERVIER

USPTO serial 79214952

WEHEALTH BY SERVIER

Reviewed by CopyMark Law Group

Reg. 5808887Status 709
Filing date
Status date
Registration date
Jul 23, 2019
Examiner
ROSENTHAL, AARON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with WEHEALTH BY SERVIER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, medical and veterinary preparations for the prevention and the treatment of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; sanitary products for medical purposes, namely, sanitary towels, sanitary napkins, sanitary sterilizing preparations; dietetic food adapted for medical or veterinary use; food for babies; dietary food supplements for humans and animals; plasters for medical purposes, namely material for dressings; materials for dental fillings and dental impressions; disinfectants; preparations for destroying vermin; fungicides; herbicidesSECTION 71 - CANCELLED—
009Scientific apparatus and instruments for use in the fields of cardiovascular, immune-inflammatory, respiratory, neurodegenerative, oncological, metabolic and osteoporosis diseases and disorders, namely, optical mirrors, spectrometers and chromatography columns; Optical apparatus and instruments, namely, optical transmitters; Weighing apparatus and instruments, namely, weighing machines, weighing scales; Measuring apparatus and instruments in the nature of wearable activity trackers; Signal splitters for electronic apparatus; Teaching apparatus and instruments in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; Apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity, namely, electric current transformers, electric power distribution units; Electronic apparatus for recording, transmission or reproduction of sound or images; Blank magnetic disks; blank optical disks for sound recording; apparatus and instruments for the processing of data information, namely, central processing units; Downloadable computer software for processing information from medical monitoring devices for monitoring physical and physiological signals, for the analysis, storage and monitoring of physiological data, including diagnostic, surveillance and warning tools; Computer programs for use in connection with managing electronic data and databases, database administration, managing cloud applications, and self-automation of database-management activities ; Data processing equipment, namely, couplers; Downloadable computer software applications for diagnosis, surveillance, prevention and treatment in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; Downloadable computer software for the analysis, storage and monitoring of physiological data, in the nature of diagnostic, surveillance and warning tools; personal digital assistants; transmitters of electronic signals, for the prevention and treatment in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; Wearable computers, namely, wearable activity trackers in the nature of wirelessly connected bracelets for treating, monitoring and medically analyzing physical and physiological signals; video cameras; Wearable computers, namely, wearable activity trackers in the nature of bracelets that track physical and physiological activity and signals; application software in the field of digital health for monitoring physical and physiological signals in the field of digital healthSECTION 71 - CANCELLED—
010Medical apparatus and instruments for the treatment and prevention of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; medical apparatus and instruments for monitoring, diagnosis, surveillance and alerts relating to heart, neurological, oncological, metabolic, respiratory and physiological disorders, namely oximeters, ECG (electrocardiographs), apparatus for monitoring eye movements, body position sensors, accelerometer and also including electro-conductive clothing sold as a unit and connected bracelets sold as a unit; Artificial limbs, eyes and artificial teeth; suture materials; Medical devices, for the treatment, surveillance and prevention of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; Diagnostic and monitoring devices for medical purposes in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; Medical devices, for the treatment, surveillance and prevention of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; Diagnostic and monitoring devices for medical purposes of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disordersSECTION 71 - CANCELLED—
044Medical services; Medical services provided via the internet, namely, online medical prescription services; Medical services, namely, medical consultation for patients with cardiovascular, immune-inflammatory, respiratory, neurodegenerative, oncological, metabolic and osteoporosis diseases and disorders provided via electronic and telematic means; Medical services, namely, medical surveillance and assistance for patients with cardiovascular, immune-inflammatory, respiratory, neurodegenerative, oncological, metabolic and osteoporosis diseases and disorders provided via electronic and telematic means; health counseling services; providing information in the field of pharmaceutical services; healthcare services, namely physical therapy, athletic training for prevention of injury and therapeutic purposes, occupational therapy, nutritional counseling therapy, hormone replacement therapy, geriatric healthcare services, cardiac rehabilitation therapy, home care personalized services, counseling regarding self-medication, counseling regarding home medical treatment, individualized medical prescription services, provision of support in the follow-up of patients receiving medical treatment, remote medical monitoring of patients; telemedicine services, namely, physical therapy, athletic training for prevention of injury and therapeutic purposes, occupational therapy, nutritional counseling therapy, hormone replacement therapy, geriatric healthcare services, cardiac rehabilitation therapy, home care personalized services, counseling regarding self-medication, counseling regarding home medical treatment, individualized medical prescription services, provision of support in the follow-up of patients receiving medical treatment, remote medical monitoring of patients, all of the aforesaid services provided remotely ; therapeutic services, namely, physical therapy, athletic training for prevention of injury and therapeutic purposes, occupational therapy, nutritional counseling therapy, hormone replacement therapy, geriatric healthcare services, cardiac rehabilitation therapy, home care personalized services, counseling regarding self-medication, counseling regarding home medical treatment, individualized medical prescription services, provision of support in the follow-up of patients receiving medical treatment, remote medical monitoring of patients; medical diagnosis of cardiovascular, immune-inflammatory, respiratory, neurodegenerative, oncological, metabolic and osteoporosis diseases and disorders; medical diagnostic services of cardiovascular, immune-inflammatory, respiratory, neurodegenerative, oncological, metabolic and osteoporosis diseases and disorders provided via electronic and telematic meansSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 6, 2026C71TCANCELLED SECTION 71—
Jul 23, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 27, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 27, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 27, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 27, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 10, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 12, 2019XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Nov 12, 2019XXCRGENERIC MADRID TRANSACTION CREATED—
Oct 23, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 23, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 31, 2019GPNXNOTIFICATION PROCESSED BY IB—
May 7, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 7, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 14, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 15, 2019OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 30, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 30, 2019OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 18, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Dec 18, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 18, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 18, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 19, 2018ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 19, 2018PBMRWITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST—
Sep 24, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 18, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 17, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 17, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
May 22, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 22, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 22, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 23, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 22, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 22, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 29, 2017RFNPREFUSAL PROCESSED BY IB—
Sep 14, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 14, 2017RFRRREFUSAL PROCESSED BY MPU—
Sep 10, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 9, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 30, 2017DOCKASSIGNED TO EXAMINER—
Aug 30, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 24, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance